C12N 2750/00043
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2750/00043 (Viral genome or elements thereof as genetic vector) appears on 20 US grants and 58 published applications in this corpus.
Search patents in C12N- Granted patents
- 20
- Published applications
- 58
- Assignees
- 23
- Inventors
- 92
- Latest grant
- 15 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 2 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 1 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 2 |
| 2015 | 1 | 7 |
| 2016 | 2 | 2 |
| 2017 | 2 | 0 |
| 2018 | 3 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 4 |
| 2021 | 3 | 3 |
| 2022 | 2 | 5 |
| 2023 | 0 | 9 |
| 2024 | 2 | 10 |
| 2025 | 1 | 6 |
| 2026 | 3 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for recombinant parvovirus production15 Sep 2026US 12,735,724 B2Aavnergene Inc.
- Anellosomes and methods of use26 May 2026US 12,637,693 B2Flagship Pioneering Innovations V, Inc.
- Surface-modified viral particles and modular viral particles3 Feb 2026US 12,540,337 B2Flagship Pioneering Innovations V, Inc.
- Compositions and methods for regulating production of an antibody like protein and ribonucleic acid16 Sep 2025US 12,415,850 B2Wyvern Pharmaceuticals Inc.
- Compositions and methods for regulating production of an antibody like protein and ribonucleic acid10 Dec 2024US 12,162,927 B1Wyvern Pharmaceuticals Inc.
- Compositions and methods for screening 4r tau targeting agents23 Jul 2026US 2026/0209296 A1Regeneron Pharmaceuticals, Inc.
- Surface-modified viral particles and modular viral particles9 Apr 2026US 2026/0098280 A1Flagship Pioneering Innovations V, Inc.
- Anellosomes for delivering secreted therapeutic modalities8 Jan 2026US 2026/0009050 A1Flagship Pioneering Innovations V, Inc.
- Compositions comprising modified anellovirus capsid proteins and uses thereof16 Oct 2025US 2025/0320465 A1Flagship Pioneering Innovations V, Inc.
- Novel anelloviridae family vector compositions and methods3 Jul 2025US 2025/0213725 A1Flagship Pioneering Innovations V, Inc.
Most cited
By later US patents
- Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor12US 8,945,918 B2Virovek, Inc. · 2015
- Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor7US 9,879,279 B2Virovek, Inc. · 2018
- Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor6US 9,879,282 B2Virovek, Inc. · 2018
- Anellovirus compositions and methods of use4US 11,446,344 B1Flagship Pioneering Innovations V, Inc. · 2022
- Specific TT virus sequences and chimeric TT virus host cell DNA molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity3US 9,624,511 B2Deutsches Krebsforschungszentrum · 2017